Purchase Order 19TH2021P1049

This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the MAGNA PURE 96 INSTRUMENT IVD, with a ceiling value of $90,000.00 and a completion date of July 15, 2017. Roche Diagnostics has received numerous federal contract awards, including through its...

This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the MAGNA PURE96 INSTRUMENT. The contract has a ceiling value of $91,563.00 and an ultimate completion date of August 31, 2017. The contract is not designated as a set-aside. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to...

This federal contract award, with an ID of HHSD2002017M93189P, was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for the procurement of a MAGNA PURE 96 INSTRUMENT WITH ACCESSORIES. The fixed-price contract has a ceiling value of $105,000.00 and an ultimate completion date of March 30, 2017. Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory...

This $90,000.00 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for MAGNA PURE 96 products. The contract has no set-aside designation and has a completion date of July 23, 2022. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. They have previously received prime contract and subcontract awards from various federal...

This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Roche Diagnostics Corporation for the MAGNA PURE 96 IVD INSTRUMENT. The contract has a ceiling value of $105,000.00 and an ultimate completion date of March 21, 2016. The contract is not designated as a set-aside. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of MAGNA PURE 96 INSTRUMENTS. The contract, which has a potential value of $180,000.00, does not have a set-aside designation and has an anticipated completion date of April 15, 2022. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics,...

This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Roche Diagnostics Corporation to provide MAGNA PURE 96 EXTERNAL LYSIS BUFFER - REAGENT. The contract has a ceiling value of $25,820.10 and an ultimate completion date of September 30, 2021. The contract was awarded on August 30, 2021 and does not have a set-aside designation. Roche Diagnostics Corporation, a manufacturer and distributor of in vitro...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for MAGNA PURE KIT. The potential value of the contract is $118,665.00 and the completion date is March 31, 2022. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract does...

The Department of the Army Medical Command awarded a firm-fixed-price purchase order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, to provide a MAGNA PURE 96 INSTRUMENT IVD. The contract has a potential value of $194,000.00 and a completion date of January 11, 2021. This award was made through a special notice solicitation using simplified acquisition procedures and was not set aside for any...

The Department of the Army Medical Command awarded a $126,906.56 firm fixed price purchase order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for the supply of the MAGNA PURE 96 INSTRUMENT IVD and associated reagents, supplies, consumables, and maintenance. This sole source award was issued under the authority of 41 U.S.C. 1901 due to the urgency of the requirement or the availability of only one reasonably qualified source. The award was not set aside...